🇺🇸 FDA

Company profile · Sponsor

Tour

Tour Hekla

EB0CB5C · EMA pharma EU
Pipeline
24
Drugs
0
Patents
0

Quick answer

Tour (EB0CB5C) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EB0CB5C
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (24)

Search pipeline →

  1. ACTILYSE, poudre et solvant pour solution injectable et perfusion, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 10,000 units powder and solvent for solution for injection, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 5 000 units (25 mg) powder for solution for injection

    Tour

    Acute ischaemic stroke due to basilar artery occlusion.

    phase 3 small molecule active

    1 trial

  2. AMIKACINE VIATRIS 1 g, poudre pour solution injectable en flacon, CHLORURE DE SODIUM 0,9 % COOPER, solution pour perfusion

    Tour

    Patients with ventilator-associated tracheobronchitis

    phase 3 small molecule active

    1 trial

  3. ASPRO 320 mg, comprimé, CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, DICLOFENAC ARROW 1 %, gel en flacon pressurisé

    Tour

    Thrombotic episodes in superficial venous malformations in children

    phase 3 small molecule active

    1 trial

  4. Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion, Midazolam Lek 1 mg/ml raztopina za injiciranje/infundiranje

    Tour

    Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:

    phase 3 small molecule active

    1 trial

  5. FOSFOMYCIN , SULFAMETHOXAZOLE AND TRIMETHOPRIM

    Tour

    Benign Prostate Hyperplasia

    phase 3 small molecule active

    1 trial

  6. Medical Air, KALINOX 50%/50%, gaz médicinal comprimé

    Tour

    Resistant Depression in the Elderly Subject

    phase 3 small molecule active

    1 trial

  7. OXYGENE MEDICINAL LIQUIDE AIR LIQUIDE SANTE FRANCE, gaz pour inhalation, pour évaporateur fixe

    Tour

    Hypoxemic acute respiratory failure

    phase 3 small molecule active

    1 trial

  8. PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN

    Tour

    Recurrent Erysipelas in lower limbs

    phase 3 small molecule active

    1 trial

  9. RIFADINE 300 mg, gélule, ANSATIPINE 150 mg, gélule

    Tour

    Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy)

    phase 3 small molecule active

    1 trial

  10. SODIUM CHLORIDE , RITUXIMAB, MYCOPHENOLIC ACID

    Tour

    Intersitial lung disease related to systemic sclerosis

    phase 3 small molecule active

    1 trial

  11. CASPONEB - Phase II safety lead-in randomized blind placebo controlled clinical trial : efficacy and safety of caspofungin aerosols for the curative treatment of Pneumocystis pneumonia in adjunction of conventional systemic antifungal therapy

    Tour

    Pneumocystis pneumonia

    phase 2 other active

    1 trial

  12. Comirnaty JN.1 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, LVT-001

    Tour

    Healthy volunteers

    phase 2 small molecule active

    1 trial

  13. JNJ-63723283, JNJ-42756493, JNJ-42756493, JNJ-42756493

    Tour

    Muscle-invasive bladder cancer (MIBC)

    phase 2 small molecule active

    1 trial

  14. KALINOX 50%/50%, gaz medicinal comprime, Medical Air

    Tour

    psychiatry

    phase 2 small molecule active

    1 trial

  15. KALINOX 50%/50%, gaz medicinal comprime, Medical Air

    Tour

    Treatment of suicidal ideation

    phase 2 small molecule active

    1 trial

  16. L-Histidine, L-Histidine monohydrochloride monohydrate, Mannitol, Sucrose, Disodium EDTA dihydrate, Polysorbate 80, Water for injection

    Tour

    Thyroid Eye Disease

    phase 2 small molecule active

    1 trial

  17. OPDIVO 10 mg/mL concentrate for solution for infusion., YERVOY 5 mg/ml concentrate for solution for infusion

    Tour

    Unresectable locally advanced or metastatic urothelial cancer

    phase 2 small molecule active

    1 trial

  18. Propranolol 40 mg film-coated tablets, microcrystalline cellulose

    Tour

    Prevention of post-traumatic stress disorder

    phase 2 small molecule active

    1 trial

  19. Rapamune 1 mg/mL oral solution

    Tour

    Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations, presenting as clusters of cysts filled with lymph fluid or blood. They are responsible for a heavy burden even with small well-limited lesions because of oozing, bleeding, infections, or even speech, chewing or breathing impairment. Pain and aesthetic prejudice are also frequently reported

    phase 2 small molecule active

    1 trial

  20. Tecentriq 1 200 mg concentrate for solution for infusion

    Tour

    Muscle-invasive bladder cancer

    phase 2 small molecule active

    1 trial

  21. VAXIGRIPTETRA, suspension injectable en seringue préremplie Vaccin grippal quadrivalent (inactivé, à virion fragmenté)

    Tour

    patients with stable coronary artery disease

    phase 2 small molecule active

    1 trial

  22. Xarelto 2.5 mg film-coated tablets

    Tour

    Chronic hemodialysis

    phase 2 small molecule active

    1 trial

  23. CHLORURE DE SODIUM 0,9 % VIAFLO, solution pour perfusion, Avastin 25 mg/ml concentrate for solution for infusion.

    Tour

    1st line treatment for unresectable metastatic colorectal cancer

    approved small molecule active

    1 trial

  24. Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)

    Tour

    Asymptomatic Child-Pugh A5 to B8 cirrhosis

    approved small molecule active

    1 trial

Frequently asked questions

What is Tour?

Tour (EB0CB5C) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Tour sponsor?

We track 24 ClinicalTrials.gov-linked programs for Tour, including ACTILYSE, poudre et solvant pour solution injectable et perfusion, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 10,000 units powder and solvent for solution for injection, ACTILYSE, poudre et solvant pour solution injectable et perfusion, Metalyse 5 000 units (25 mg) powder for solution for injection and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Tour company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.